Corteva participates in an industry that is highly competitive and has undergone consolidation, which could increase competitive pressures.
The successful development and commercialization of Corteva’s pipeline products will be necessary for Corteva’s growth.
Corteva may not be able to obtain or maintain the necessary regulatory approvals for some of its products, including its seed and crop protection products, which could restrict its ability to sell those products in some markets.
Enforcing Corteva’s intellectual property rights, or defending against intellectual property claims asserted by others, could adversely affect Corteva’s business, results of operations and financial condition.
Corteva’s business may be adversely affected by competition from manufacturers of generic products.
Corteva is dependent on its relationships or contracts with third parties with respect to certain of its raw materials or licenses and commercialization.
The costs of complying with evolving regulatory requirements could negatively impact Corteva’s business, results of operations and financial condition. Actual or alleged violations of environmental laws or permit requirements could result in restrictions or prohibitions on plant operations, substantial civil or criminal sanctions, as well as the assessment of strict liability and/or joint and several liability.
The degree of public understanding and acceptance or perceived public acceptance of Corteva’s biotechnology and other agricultural products and technologies can affect Corteva’s sales and results of operations by affecting planting approvals, regulatory requirements and customer purchase decisions.
Changes in agricultural and related policies of governments and international organizations may prove unfavorable.
Corteva’s business, results of operations and financial condition could be adversely affected by disruptions to its supply chain, information technology or network systems.
Corteva’s sales to its customers may be adversely affected should a company successfully establish an intermediary platform for the sale of Corteva’s products or otherwise position itself between Corteva and its customers.
Volatility in Corteva’s input costs, which include raw materials and production costs, could have a significant impact on Corteva’s business, results of operations and financial condition.
Corteva may be unable to achieve all the benefits that it expects to achieve from the Internal Reorganization. Combining the agriculture businesses of EID and Historical Dow may be more difficult, costly or time-consuming than expected, which may adversely affect Corteva’s results and negatively affect the value of Corteva common stock.
Corteva’s liquidity, business, results of operations and financial condition could be impaired if it is unable to raise capital through the capital markets or short-term debt borrowings.
Corteva’s customers may be unable to pay their debts to Corteva, which could adversely affect Corteva’s results.
Increases in pension and other post-employment benefit plan funding obligations may adversely affect Corteva’s results of operations, liquidity or financial condition.
Corteva’s business, results of operations and financial condition could be adversely affected by environmental, litigation and other commitments and contingencies.
Corteva’s operations outside the United States are subject to risks and restrictions, which could negatively affect Corteva’s business, results of operations and financial condition.
Climate change and unpredictable seasonal and weather factors could impact Corteva’s sales and earnings.
Corteva’s business may be adversely affected by the availability of counterfeit products.
Failure to effectively manage acquisitions, divestitures, alliances and other portfolio actions could adversely impact Corteva’s future results.
An impairment of goodwill or intangible assets could require Corteva to record a significant non-cash charge and negatively impact Corteva’s financial results.
Discontinuation, reform or replacement of the London Interbank Offered Rate (“LIBOR”) and other benchmark rates, or uncertainty related to the potential for any of the foregoing, may adversely affect our business.
Net sales were $5,556 million and $5,731 million for the three months ended June 30, 2019 and 2018, respectively. The decrease was primarily driven by weather-related delays driving lower expected planted area in corn, soybeans and canola in North America, unfavorable currency impacts driven predominately by the Euro, and competitive pricing pressures for soybeans in North America, partially offset by strong demand for new products, including IsoclastTM insecticides, ZorvecTM fungicides and ArylexTM herbicides.
Net sales were $8,952 million and $9,525 million for the six months ended June 30, 2019 and 2018, respectively. The decrease was primarily driven by weather-related delays, driving lower expected planted area in corn, soybeans and canola in North America and negatively impacting soybean herbicide and nitrogen stabilizer applications, as well as unfavorable currency impacts driven predominately by the Euro, partially offset by strong demand for new products in Latin America and EMEA.